Stroke Trial, Recruiting NCT04962646 Sponsor: Region Skane Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT04962646
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a confirmed acute Type A aortic dissection (a serious tear in the main blood vessel leaving the heart).
  • People who have been accepted to have surgery to repair the dissection.

Who may not be able to join:

  • People who are showing new neurological symptoms at the time of enrolment, such as weakness or numbness on one side of the body, or a reduced level of consciousness.
  • People who have had a stroke in the past that left permanent neurological effects.
  • People who have had heart surgery before.
  • People whose surgery is performed using a specific technique that involves clamping the aorta without opening and directly inspecting the lower part of the aorta during the procedure (confirm with trial site).
  • People who have implants or devices in their body that are not safe to use with MRI (magnetic resonance imaging) scans, such as certain pacemakers or metal implants.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Igor Zindovic, MD. PhD, Region Skåne, Skåne university hospital

Phone: +4646175288

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Region Skane
Registry
ClinicalTrials.gov
Start date
1 January 2022
Est. completion
30 June 2025

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Number of ischemic lesions on magnetic resonance imaging (MRI); Size of ischemic lesions on magnetic resonance imaging (MRI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov